HOME >> BIOLOGY >> NEWS
Early predictor of breast cancer aggressiveness

Physicians may be able to make early decisions on the best treatment for breast cancer, thanks to research published in Breast Cancer Research today. A gene involved in the adhesion of cells is less active in breast tumors with a poor prognosis than those that are less aggressive, researchers found.

Measuring the activity of the ALCAM gene in primary breast tumors could give physicians advanced warning about the likely clinical outcome of the disease. This should help them decide whether to prescribe a more aggressive treatment regimen, such as chemotherapy, much earlier in the diagnostic process.

Dr Judy King and colleagues, from University of South Alabama and University of Wales College of Medicine, compared the expression of the gene for the Activated Leukocyte Cell Adhesion Molecule (ALCAM) in normal breast tissue and tissue samples from primary breast tumors. To do this they counted the number of mRNA transcripts of the ALCAM gene in the different samples.

The researchers found that the ALCAM gene was significantly less active in higher-grade tumors compared to lower-grade tumors, and in tumors with a worse prognosis compared to those with a better prognosis.

"Tumors from patients who died of breast cancer had significantly lower levels of ALCAM transcripts than those with primary tumors but no metastatic disease or local recurrence," write the researchers.

They continue: "The data clearly suggest that decreased ALCAM expression in the primary tumor is of clinical significance in breast cancer, and that reduced expression indicates a more aggressive phenotype and poor prognosis."

They suggest that quantitative PCR, to measure the number of ALCAM transcripts in a tissue sample from a primary breast tumor, could be used to identify these more aggressive tumors at an early stage.

As ALCAM is involved in keeping cells together in a clump, the researchers hypothesize that reduced expression of the gene might
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-631-9931
BioMed Central
27-Jun-2004


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early treatment confirmed as key to stroke recovery
6. Early identification of kidney disease cost-effective only when directed at high-risk patients
7. Early promise for treatment of Ebola
8. Early treatment can prevent severe vision loss in premature infants
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/2/2018)... ... August 02, 2018 , ... RxS LLC (“RxS”), a privately ... announced that Mark Jara, principal of the organization, has been named to PharmaVOICE ... Individuals named to PharmaVOICE 100 are leaders who drive the industry forward and ...
(Date:8/1/2018)... Md. (PRWEB) , ... August 01, 2018 , ... ... software portfolio, announces the release of Limfinity® version 7.1. Limfinity® is the software ... to Limfinity® itself creates new possibilities for both current users and the future ...
(Date:8/1/2018)... JUPITER, Fla. (PRWEB) , ... August 01, 2018 ... ... “YOU” the staff NP, PA’s, RN’s, LPN’s, MA's and Administrative staff. , This ... processing of all the biologics. The course will expose your staff to regenerative ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... ... managing clinical trial patient and supplies data through its flagship IXRS® 3 ... IRT: Best Practices.” , This podcast features both Almac thought leaders and outside ...
(Date:7/24/2018)... ... July 24, 2018 , ... R3 Stem Cell is ... Vegas. The treatments are offered by Double Board Certified providers, with outcomes significantly improving ... with suppressing symptoms, but have done nothing to help repair and regenerate damaged lung ...
(Date:7/22/2018)... ... July 19, 2018 , ... CallTower ... joined their team. With more than ten years of strategic, result-oriented Channel experience ... expertise as CallTower’s Channel Director for the Southwest and Mountain region. , As ...
(Date:7/22/2018)... ... July 20, 2018 , ... ... automation and IT solutions with 150 employees on both the east and west ... Program. Superior Controls met the high criteria for application expertise, operational excellence ...
Breaking Biology Technology:
Cached News: